‌

US Patent 9879269 Method for modulating resistance

Patent 9879269 was granted and assigned to IFF Nutrition & Biosciences on January, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

IFF Nutrition & Biosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Christophe Fremaux0

Dennis A. Romero0

Patrick Boyaval0

Philippe Horvath0

Rodolphe Barrangou0

Date of Patent

January 30, 2018

0

Patent Application Number

134900500

Date Filed

June 6, 2012

0

Patent Citations Received

US Patent 11911415 CRISPR/Cas-related methods and compositions for improving transplantation

0

US Patent 12110545 Methods of assessing nuclease cleavage

0

US Patent 12076375 Treating and preventing

0

US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing

0

US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing

0

0

US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites

0

US Patent 11788085 Treating and preventing microbial infections

Patent Primary Examiner

0

Patent abstract

The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9879269 Method for modulating resistance

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.